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The FHA domain is a phospho-peptide binding module involved in a wide range of cellular pathways, with
a striking specificity for phospho-threonine over phospho-serine binding partners. Biochemical, structural,
and dynamic simulations analysis allowed Pennell and colleagues to unravel the molecular basis of FHA
domain phospho-threonine specificity.Intracellular signaling processes that
mediate key cellular events such as the
cell cycle and the response to DNA
damage critically rely on cascades of
serine/threonine protein phosphorylation.
Ser/Thr phosphorylation drives interac-
tions between proteins through the recog-
nition of the phosphorylated peptide by
a number of distinct protein domains
that exhibit an impressive degree of
selectivity for the sequence of the peptide
target (Yaffe and Smerdon, 2004).
Perhaps one of the most intriguing as-
pects of phospho-peptide binding speci-
ficity is the ability of certain domains to
distinguish between phospho-serine
(pSer) and phospho-threonine (pThr) in
the peptide. The most dramatic example
is found in the family of FHA domains,
which all exhibit a profound selectivity
for pThr over pSer-containing phospho-
peptides. In this issue of Structure,Figure 1. Structure of the Rad53p FHA Bound to a Cognate pThr-
Containing Peptide
(A) Overview of the Rad53p FHA phospho-peptide complex.
(B)Detailed viewof FHAphospho-peptide interactions, highlighting key residues
that contact the pThr and downstream residues in the phospho-peptide target.Pennell et al. (2010) use
a combination of crystallo-
graphic, biochemical, and
computational approaches
to provide a detailed struc-
tural mechanism for this
selectivity, which is likely
conserved throughout the
FHA protein family.
FHA, or forkhead-associ-
ated, domains, initially identi-
fied in the forkhead family
of transcription factors, are
found in both prokaryotic and
eukaryotic organisms (Hof-
mann and Bucher, 1995). The
role of the FHA as a phos-
pho-peptide binding domain
was first revealed in studies
of the FHA domains of the
S. cerevisiae DNA damagesignaling kinase, Rad53p (Durocher et al.,
1999, 2000). These studies revealed that
both FHA domains within Rad53p could
independently bind phospho-peptides
with marked specificity for the identity of
the side chain three residues C-terminal
to the site of phosphorylation. Intriguingly,
they also showed a dramatic preference
for pThr over pSer peptides. While these
binding specificities appear tobecommon
inothermembersof theFHA family, certain
unique preferences have also been
observed (Liang and Van Doren, 2008;
Mahajan et al., 2008). For example,
a subfamily of the FHA domains, first iden-
tifiedwithin the DNA repair protein polynu-
cleotide kinase, recognize highly acidic
peptide targets, often containing multiple
sites of phosphorylation (Ali et al., 2009).
Structural studies on FHA domains have
revealed a common architecture consist-
ing of an 11-stranded b sandwich. TheStructure 18, December 8, 2010 ªphosphorylated peptide binds three
different loops that protrude from one
end of the b sandwich (b4-b5, b6-b7, and
b10-b11) (Figure 1A). The only two
conserved residues of these loops, an
Arg and a Ser, provide two of the ligands
for the phosphate group, while additional
ligands are provided by other less well-
conserved residues (Figure 1B). In addi-
tion, a second shallow pocket serves to
provide binding specificity for the amino
acid at the +3 position with respect to the
pThr.
In this issue, Pennell et al. (2010) probe
the basis for pThr-dependent FHA interac-
tions through the study of the FHA domain
of Mycobacterium tuberculosis Rv0020c.
They use oriented peptide library
screening to select peptides that bind
this previously uncharacterized domain
with high affinity, revealing a significant
preference for pThr peptides containing2010 Elsevia small/medium hydrophobic
residue at the pThr +3 posi-
tion. The thermodynamic
contributions of specific resi-
dues to binding energetics
were probed by isothermal
titration calorimetric peptide-
binding measurements of an
extensive set of peptide and
FHA mutants. These experi-
ments further support the
importance of the pThr +3
residue and reveal an ener-
getic coupling of the peptide
+3 residue with the pThr 1
residue. They went on to
determine the structure of the
Rv0020c FHA domain, both
free and in complex with
an optimal phopho-peptide
target. Building on this higher Ltd All rights reserved 1549
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Previewsresolution structural data, they used
molecular dynamics simulations to specif-
ically address the mechanism of selective
recognition of pThr- versus pSer-contain-
ing peptides. The simulations indicate
that while binding of either the pThr or
pSer peptide induces a significant stabili-
zation of the FHA, the effect is much
more pronounced for the pThr peptide.
The pThr-dependent stabilization relies
upon limited contacts between the pThr
g-methyl group and a small pocket on the
FHA composed of residues including
a highly conserved asparagine residue
(Asn495 in Rv0020c), which makes critical
contacts to the phospho-peptide back-
bone bridging the +1 and +3 residues.
Loss of this contact in the complex with
the pSer peptide results in a higher degree
of overall flexibility, in particular in the
regions directly in contact with the pSer
as well as Asn495. Taken together, this
work presents a satisfying explanation for1550 Structure 18, December 8, 2010 ª2010how the loss of a small van der Waals
contact surfacecan trigger thedestabiliza-
tion of the entire FHA-peptide interface,
a mechanism that is likely conserved
throughout the FHA protein family.
We are beginning to understand the
detailedmechanisms of phospho-peptide
binding specificity for many of the critical
protein modules that regulate intracellular
signaling pathways. While additional
details remain to be ironed out—for
example, how certain BRCT domains
selectively bind pSer- over pThr-peptides
(Manke et al., 2003)—ultimately we will
need to understand the impact of these
interactions on the intact protein
complexes that regulate phosphoryla-
tion-dependent signaling.REFERENCES
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In this issue ofStructure, Reymond et al. (2010) combinemolecular and computational biology approaches to
provide structural details for intermediates in the folding pathway of the hepatitis delta virus ribozyme.RNA molecules perform a wide array of
complexmolecular functions. For example,
they star in roles of ligand sensors as ribos-
witches and of catalysts as ribozymes.
These active roles are in addition to what
can be thought of as their more mundane
function in the transfer of genetic informa-
tion in the guise of mRNA and tRNA. To
date, a wide array of RNA structures have
beendeterminedthatdescribe thecomplex
three-dimensional structures formed by
awide variety of functional RNAmolecules.
As is often the case, one question leads to
another, and the question of how an RNA
strand folds into complex active structures
is one that is attracting attention.
In many ways RNA is a simple mole-
cule. The primary sequence of RNA iscomposed of just four different bases, yet
this limited selection of monomers allow
RNA to form diverse and stable secondary
structures that then fold into the native
tertiary structure (Woodson, 2010). The
intermolecular forces that govern RNA
folding are the same as for its protein
cousin; hydrogen bonding, van der Waals
interactions, hydrophobic effects, and
electrostatics all play a role, often in
a RNA-specific fashion. For example, the
electrostatics of RNA folding are complex
compared with the case of proteins, due
to the negative charge on the phosphate
backbone and the need for counter ions
to screen this charge and facilitate close
contact in the folded state (Chu et al.,
2008). In the process of folding, RNAhas a particular propensity to formalterna-
tive non-native structures before reaching
a final structure; it is these structural inter-
mediates between the unfolded and
folded state that define an RNA folding
pathway (Solomatin et al., 2010). The time-
scales involved in an RNA folding event
vary widely with respect to the size of
RNA molecule and type of structure being
formed.Helices and stem loops fold on the
order of microseconds, while the packing
of helices into the tertiary structure can
take milliseconds to hundreds of seconds
(Woodson, 2010). The intermediaries may
be local minima on the RNA folding land-
scape and could be branch points for
unproductive folding routes as different
tertiary structures are explored.
